Results from the PrognoScan database17 showed that breast cancer patients with low expression of TSPAN13 had shorter survival time (GSE12276 dataset, n = 204, P = 0.001299, Figure 4H) than those with high TSPAN13 expression. Here, TSPAN13 is linked to breast carcinoma.